2021 Updates in Hematologic Malignancies

Salt Lake City, UT US
October 2, 2021

The 2021 Updates in Hematologic Malignancies features leading experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues. Participants will have a chance to hear experts' perspectives on novel treatment strategies and management of treatment-related toxicities in the management of patients with hematologic malignancies. This activity aims to improve the knowledge, competence, and performance of healthcare professionals in the evidence-based management of hematologic malignancies. 

Abstract Presentations

Abstract Presentation Schedule has been emailed to all accepted abstract authors. 

All presenters must be fully vaccinated against COVID-19 to be able to present their abstracts. 

You must be registered for the conference to present your abstract. If you are a resident or fellow presenting the abstract, please follow the instructions for fellow/resident registration to receive a registration fee waiver. 

Target Audience

  • Hematologists/Oncologists
  • Oncology Nurse Practitioners
  • Oncology Pharmacists
  • Oncology Physician Assistants
  • Oncology Fellows/Residents
  • Oncology Nurses
  • Researchers and others involved in the care of cancer patients

COVID-19 precautions:

COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in. 

Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review pertinent clinical trial data for the standard of care and novel management strategies for various hematologic malignancies.
  • Integrate and optimally sequence evidence-based treatment plans for various hematologic malignancies based on patient and tumor factors.
  • Discuss the mechanism of action, efficacy, indications, and safety of novel targeted therapies and cellular therapies for the management of hematologic malignancies.
  • Review current controversies in the management of various hematologic malignancies.
  • List appropriate clinical trials for hematologic malignancies
Course summary
Course opens: 
05/09/2021
Course expires: 
11/30/2021
Event starts: 
10/02/2021 - 7:15am
Event ends: 
10/02/2021 - 5:15pm
Cost:
$200.00

Conference Chair: Srinivas Tantravahi, MD

All times are listed in local venue time zone (Mountain Time)

6:30 AM to 7:45 AM              Breakfast and Registration

7:45 AM to 8:00 AM              Opening Remarks 


8:00 AM to 9:30 AM             Session 1: Lymphomas

Moderator: Lindsay Fitzgerald, MD

8:00 AM to 8:30 AM              Hodgkin lymphoma – Harsh Shah, DO

8:30 AM to 9:00 AM              Aggressive lymphomas – Ryan Lynch, MD

9:00 AM to 9:30 AM              Chronic lymphocytic leukemia – Deborah Stephens, DO

9:30 AM to 10:00 AM            CAR-T cell therapy for the treatment of Lymphoma –

                                                     Catherine Lee, MD

 


 10:00 AM to 10:30 AM          BREAK

10:00 AM to 10:30 AM      Breakfast and Learn with Dr. Amit Mehta in the Topaz Room*

Stand Strong Against Platelet Destruction with TAVALISSE: A Patient’s ITP Treatment Journey

Presented by - Rigel Pharmaceuticals, Inc.

*This program is not part of the CME activity.


10:30 AM to 12:00 PM         Session 2: Leukemias 

Moderator: Ashley Newland, PharmD 

10:30 AM to 11:00 AM          Acute Myeloid Leukemia – Krishna Gundabolu, MD

10:30 AM to 11:00 AM          Acute lymphoblastic leukemia – Tibor Kovacsovics, MD 

11:30 AM - 12:00 PM            Case based discussion

                                               Case 1: Charlotte Wagner, PharmD

                                               Case 2: Srinivas Tantravahi, MD


12:00 PM - 01:00 PM             LUNCH


01:00 AM - 03:00 PM           Session 3: Multiple Myeloma 

Moderator: Mary Steinbach, APRN and Aman Godara, MD

01:00 PM to 01:30 PM           Front line therapy for newly diagnosed multiple myeloma –

                                                       Douglas Sborov, MD 

01:30 PM to 02:00 PM           Treatment of relapse/refractory multiple myeloma –

                                                       Shaji Kumar, MD

02:00 PM to 02:30 PM           Case - based discussion 

Case 1: Mary Steinbach, APRN

Case 2: Aman Godara, MD 


02:30 PM to 03:00 PM           BREAK 


03:00 PM to 04:30 PM          Session 4: Myeloproliferative Neoplasms

Moderator: Tashi Tsewang, MD and Laura Bickel, APRN

03:00 PM to 03:30 PM           Myeloproliferative neoplasms – Srinivas Tantravahi, MD                    

03:30 PM to 04:00 PM           Treatment free remission in chronic myeloid leukemia –

Jerry Radich, MD                                               

04:30 - 05:00 pm                    Case - based discussion

                                               Case: Laura Bickel, APRN 

 

5:00 PM to 6:00 PM - ABSTRACT SESSION in Topaz room

 

Hilton Salt Lake City Center
255 S W Temple
Salt Lake City, UT 84101
United States

 

Srinivas Tantravahi, MD

Assistant Professor of Medicine

University of Utah 

Learn More

Jerald Radich, MD

Professor of Medicine

University of Washington, SCCA, Fred Hutch 

Learn More

Amandeep Godara, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

Tsewang Tashi, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

Krishna Gundabolu, MD

Assistant Professor of Medicine

University of Nebraska

Learn More

 

 

Harsh Shah, DO

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

Ryan Lynch, MD

Assistant Professor of Medicine

University of Washington

Medical-Oncologist

Seattle Cancer Care Alliance

Learn More

 

Deborah Stephens, DO

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

Catherine Lee, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

Tibor Kovacsovics, MD

Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

Douglas Sborov, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

 

Shaji Kumar, MD

Professor of Medicine

Mayo Clinic

Learn More

Photo coming soon!

Charolette Wagner, PharmD

Huntsman Cancer Institute, University of Utah

Learn More

Laura Bickel, APRN

Advanced Practice Clinician

Huntsman Cancer Institute, University of Utah

Learn More

Mary Steinbach, APRN

Advanced Practice Clinician

Huntsman Cancer Institute, University of Utah

Learn More

    

 

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 6.5 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.5 Contact Hours.

ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Acknowledgment of commercial support

This activity has been supported with independent medical education grant(s) from the following companies:

Pfizer, Inc.

We have exhibit & Industry Sponsored Symposia opportunities available at this meeting. You can sign up to exhibit both days (2021 Precision Oncology Summit: Personalizing treatment to improve patient outcomes) & 2021 Updates in Hematologic Malignancies or only one day.

 

Register to exhibit at this conference here - Salt Lake City Conference Exhibit Registration

 

Contact Tara Shah if you have any questions. 

PLEASE VISIT OUR EXHIBITORS BELOW DURING THE EXHIBIT/BREAK/LUNCH HOURS.


Price

Cost:
$200.00
Please login or register to take this course.

COVID-19 precautions:

COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in. 

Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.


REGISTRATION FEES DETAILS

Physicians (MD/DO) - $200

Non-Physician (RN/NP/PA/PharmD) - $125 

Residents/Fellows - Free registration - see instructions below*

*If you are a resident or fellow in the United States, please create a user account on this portal using your work email, and send us an email from the email address used to create the account with the name of the conference(s) that you are interested in attending, and we will register you for free. 

*If you are a resident or fellow from outside the United States, please create a user account on this portal using your work email if available, and send us an email from the email address used to create the account with the following information, and we will register you for free. 

  • Name of the conference(s) that you are interested in attending
  • A picture ID or another document showing proof of your status as Resident/Fellow/Physician in training
  • Name and email address of program director to verify your trainee status

Non-displaying industry representative - $500

Displaying industry representative (not covered by the display fee) - $300

If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company.